Quantcast

Latest Psoriasis Stories

2015-03-20 12:27:48

- Phase IIIb CLEAR study at AAD showed over 21% more psoriasis patients achieved clear to almost clear skin (PASI 90) with Cosentyx(TM) (secukinumab) compared to Stelara® (ustekinumab) at Week 16

2015-03-19 04:21:27

CANTERBURY, England, March 19, 2015 /PRNewswire/ -- - Prestigious peer-review journal accepts paper demonstrating a reduction of pruritus (itch)

2015-03-17 16:26:27

Pivotal Results Comparing Brodalumab With Stelara® (Ustekinumab) and Placebo to be Presented in Late-Breaking Session THOUSAND OAKS, Calif., March 17, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN)

511326691
2015-03-16 11:40:28

One human antibody known as BI 655066 is a promising candidate to be used to target the inflammation-causing protein, interleukin-23.

2015-03-13 04:23:15

DALLAS, March 13, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Hidradenitis Suppurativa - Pipeline Review, H1 2015" therapeutic market research report provides an overview

2015-03-09 23:08:17

Beverly Hills’ celebrity cosmetic dermatologist and renowned expert on advanced skin treatments, Dr. Paul W.

2015-03-04 16:27:45

AUSTIN, Texas, March 4, 2015 /PRNewswire/ -- XBiotech announced today that results from its Phase II pilot study in patients with moderate to severe plaque psoriasis have been published in JAMA

2015-03-04 08:30:44

COSENTYX(TM) (secukinumab), recently FDA-approved to treat plaque psoriasis, will be available for patients through the nation's largest independent specialty pharmacy. FLINT,

2015-02-26 08:32:37

Dermatology offices, psoriasis patients encouraged to join the research efforts PORTLAND, Ore., Feb.

2015-02-25 08:32:48

Celgene Launches Psoriatic Arthritis Educational Patient-Focused Program SUMMIT, N.J., Feb.


Word of the Day
logocentrism
  • The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.
The word 'logocentrism' is a blend of logo- +‎ centrism.
Related